Movano Price to Book Ratio 2020-2024 | MOVE
Historical price to book ratio values for Movano (MOVE) over the last 10 years. The current price to book ratio for Movano as of November 12, 2024 is 1.65.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Movano Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-11-12 | 4.23 | 1.66 | |
| 2024-06-30 | 0.28 | $2.54 | 0.11 |
| 2024-03-31 | 0.41 | $-0.39 | -1.04 |
| 2023-12-31 | 0.78 | $0.93 | 0.84 |
| 2023-03-31 | 1.23 | $4.04 | 0.30 |
| 2022-12-31 | 1.30 | $3.53 | 0.37 |
| 2022-09-30 | 2.75 | $6.56 | 0.42 |
| 2022-06-30 | 2.39 | $9.36 | 0.26 |
| 2022-03-31 | 2.71 | $12.14 | 0.22 |
| 2021-12-31 | 3.80 | $14.97 | 0.25 |
| 2021-09-30 | 3.45 | $17.56 | 0.20 |
| 2021-06-30 | 5.09 | $19.66 | 0.26 |
| 2021-03-31 | 5.54 | $21.63 | 0.26 |
| 2023-09-30 | 1.09 | $1.46 | 0.75 |
| 2023-06-30 | 1.09 | $3.80 | 0.29 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.028B | $0.000B |
| Movano Inc. is a health technology company. It engages in designing devices which empower individuals to optimize their health in order to prevent and better manage chronic diseases. Movano Inc. is based in PLEASANTON, CA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $10.500B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $5.733B | 148.28 |
| Inspire Medical Systems (INSP) | United States | $5.716B | 178.27 |
| Axonics (AXNX) | United States | $3.603B | 1762.25 |
| IRhythm Technologies (IRTC) | United States | $2.729B | 0.00 |
| Privia Health (PRVA) | United States | $2.710B | 225.80 |
| Enovis (ENOV) | United States | $2.621B | 17.77 |
| Omnicell (OMCL) | United States | $2.264B | 74.08 |
| Azenta (AZTA) | United States | $2.250B | 112.17 |
| 10x Genomics (TXG) | United States | $1.898B | 0.00 |
| Schrodinger (SDGR) | United States | $1.620B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.617B | 0.00 |
| Phreesia (PHR) | United States | $1.235B | 0.00 |
| Standard BioTools (LAB) | United States | $0.763B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.586B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
| Talkspace (TALK) | United States | $0.569B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.528B | 91.40 |
| Health Catalyst (HCAT) | United States | $0.495B | 0.00 |
| Pulmonx (LUNG) | United States | $0.278B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.261B | 0.00 |
| TruBridge (TBRG) | United States | $0.234B | 67.96 |
| P3 Health Partners (PIII) | United States | $0.140B | 0.00 |
| American Well (AMWL) | United States | $0.136B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.098B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| 111 (YI) | China | $0.056B | 0.00 |
| CareCloud (CCLD) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| Outset Medical (OM) | United States | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.017B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |